Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe
Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers
CJ & L Consultancy to launch ‘Rent an eQMS’ – A ready-to-use Compliance Solution on 1st November 2025
Start-ups and small businesses can now access a fully functioning Electronic Quality Management System (eQMS) without the heavy investment of building one in-house. Designed to meet ISO 9001, 13485, 27001, and 45001, our eQMS is adaptable, secure, and available immediately — so you can stay compliant and audit-ready from day one.
Leading Hospital charity in East of England praised for investing early on in promising medical professionals’ careers – helping to bring breakthroughs and change in patient care and treatments
Leading hospital charity Addenbrooke's Charitable Trust (ACT) this year celebrates its 30th anniversary - with its supporters donating more than £150 million towards supporting innovation in patient care. One area the charity is able to invest in is research and fellowships - investing in promising medical professionals early in their careers. At this year's John Addenbrooke Lecture, Roland…
Prizes for team behind game-changing multi-omics method to decode gene regulation
Babraham Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and gene expression in single cells. Lead researchers, Peter Rugg-Gunn and Yang Wang, received the Top Rising Star award by BioCentury Grand Rounds in recognition of the outstanding translational potential of the scMTR-seq method.
Tagomics publishes a new approach to genome-wide epigenomic profiling
Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsyActivace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive
How to solve in-building connectivity issues
Solve in-building wireless challenges without the long timelines.Wilson Connectivity’s Hybrid DAS combines proven amplifier technology with fibre-optic reach, enabling rapid deployment for buildings from 100k to 500k sq ft.
The results:
Building bridges at the Oxford Med-Tech Fair: EFEC’s UK–China life sciences vision
EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners.
Guardtech support staff member’s epic trek for cancer charity close to the business’ heart
The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemic
Miebach Consulting doubles footprint on Abingdon Science Park
Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth
Universal drug target potential in scaffolding cells found across the body
Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").
Invent: Life Sciences podcast - make way for advanced therapies – why manufacturing could be coming to a hospital near you
Season 3, Episode 6. In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients.
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enough
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner.
Wilson Connectivity’s Hybrid DAS
Corporate campuses, schools, and hospitals can’t wait years for wireless coverage. With Wilson Connectivity’s Hybrid DAS, reliable service is live in weeks.
Quantum computing and AI: Synergy or deep tech rivalry?
In this article, IDTechEx explores the fascinating relationship between quantum computing and AI: two supposed tech revolutions that frequently grab the spotlight. Underneath the hype, there exist both technical synergies and competing market forces.
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expressionPortfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetrationNew distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen local technical support
A leading hospital charity thanks its Daily Mirror Pride of Britain Regional Fundraiser of the Year nominee – saying they "couldn’t be prouder”
This year's Daily Mirror Pride of Britain Awards will be televised live on ITV next month. Prior to all the finalists getting through, they go through a process where regional news teams select a fundraiser from the 17 regions across the UK. For the second year running, a fundraiser from hospital charity Addenbrooke's Charitable Trust was nominated for ITV Anglia's Regional Fundraiser of the…
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinvention
TRIMTECH Therapeutics named as one of Fierce Biotech’s ‘Fierce 15’ for 2025
Fierce 15 highlights pre-commercial biotech companies driving the next generation of therapies for patients worldwide
Invent: Life Sciences podcast - Automation, Access, and the Future of Manufacturing
Manufacturing can make or break the future of cell and gene therapy. In this episode, Stuart sits down with two expert guests to share how smart design, automation, and closed systems are helping to lower costs, reduce complexity, and make therapies more accessible.
Abselion introduces Protein G Total Antibody Quantification Kit
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform
25 Years of Guardtech – a new era for cleanroom furniture & equipment fit-outs with Guardware
Suffolk-based cleanroom construction specialists the Guardtech Group have launched a new cleanroom furniture & equipment website to take their Guardware Cleanroom Hardware brand to the next level.